Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
Pemphigus risk following programmed death receptor-1, programmed death ligand-1, or cytotoxic T-lymphocyte-associated protein 4 inhibitors: A 1:1 propensity-matched, global, retrospective cohort study.
Journal: JAAD international
Published: March 04, 2025
Pemphigus Is Associated with an Increased Odds of Hypertrophic/Keloidal Scarring: A Retrospective, Population-Based Cohort Study.
Journal: The Journal of investigative dermatology
Published: February 05, 2025
Advances in Pemphigus and Pemphigoid: A Report of the International Meeting of the Pemphigus and Pemphigoid Foundation in Thessaloniki, Greece.
Journal: JID innovations : skin science from molecules to population health
Published: November 01, 2024
Data-Driven Image Analysis to Determine Antibody-Induced Dissociation of Cell-Cell Adhesion and Antibody Pathogenicity in Pemphigus Vulgaris.
Journal: bioRxiv : the preprint server for biology
Published: October 17, 2024
Data-driven image analysis to determine antibody-induced dissociation of cell-cell adhesion and antibody pathogenicity in pemphigus.
Journal: PNAS nexus
Published: October 14, 2024
A comprehensive, population level evaluation of previously reported drug triggers of pemphigus highlights immunomodulatory capacity as a common characteristic.
Journal: Frontiers in immunology
Published: October 08, 2024
Healthy individuals genetically at-risk for the development of Pemphigus vulgaris or Alopecia areata share disease-like cytokine dysregulation.
Journal: Frontiers in immunology
Published: September 23, 2024
Cytokine profiling reveals HLA-linked Th2 and Th17 driven immune activation in pemphigus vulgaris patients and genetically susceptible healthy controls.
Journal: Frontiers in immunology
Published: September 23, 2024
Evaluation of link between COVID-19 adjacent spike in hydroxychloroquine use and increased reports of pemphigus: a disproportionality analysis of the FDA Adverse Event Reporting System.
Journal: Frontiers in immunology
Published: July 25, 2024
Integration of Longitudinal Clinical, Immunologic, and Environmental Data for Enhanced Disease Monitoring and Management in Pemphigus Vulgaris: A Case Study.
Journal: JID innovations : skin science from molecules to population health
Published: July 09, 2024
Response to Kasperkiewicz et al's "Pemphigus following herpes simplex infection: A global comprehensive cohort study".
Journal: Journal of the American Academy of Dermatology
Published: July 09, 2024
Last Updated: 09/26/2026